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Abstract 
Study objective: To assess the efficacy of intraoperative different inspired oxygen fractions 
(FIO2) of 0.8 and 0.5 when compared with standard FIO2 0.3 in prevention of postoperative 
nausea and vomiting (PONV).  
Design: A prospective, controlled, randomized, double-blind study.  
Setting: General hospital, postanesthesia care unit (PACU) and gynecologic floor room. 
Patients: 120 ASA physical status I and II women, aged 21 to 76 y, undergoing elective 
gynecologic laparoscopic surgery.  
Interventions: Patients were randomized to receive gas mixture of 30% oxygen in air (FI 
O2=0.3, group G30), 50% oxygen in air (FIO2=0.5, group G50) or 80% oxygen in air 
(FIO2=0.8, group G80), n=36 in each group. A standardized sevoflurane general anesthesia, 
postoperative pain management and antiemetic regimen were used.  
Measurements: The incidence of nausea, vomiting or both was assessed for early (0-2h) and 
late PONV (2-24h) along with the use of rescue antiemetic, degree of nausea and severity of 
pain. 
Main results: There was no overall difference in the incidence of PONV at early and late 
assessment periods among the three groups. Patients in G80 had significantly less vomiting 
than G30 at 2 hours, 3% (1/36) vs. 22% (8/36), respectively, P=0.028. Nausea scores, rescue 
antiemetic use, pain scores and opioid consumption were not different among the groups. 
Conclusion: High intraoperative FIO2 of 0.8 and FIO2 of 0.5 does not prevent PONV in 
patients without antiemetic prophylaxis. Intraoperative FIO2 of 0.8 has beneficial effect on 
early vomiting only. 
 
 
 
 
 
 
Introduction 
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          Gynecologic laparoscopic surgery increases the risk for postoperative nausea and 
vomiting (PONV) with an incidence as high as 80% [1]. Pharmacological prophylaxis does 
not eliminate the incidence of PONV completely and can increase the costs and the risk of 
adverse events [2]. Supplemental oxygen may be an additional simple method in multimodal 
PONV prophylaxis. The published data to date remain controversial. Intraoperative FIO2 of 
0.8 was reported as effective as ondansetron prophylaxis in women undergoing general 
anesthesia for prolonged gynecologic laparoscopic surgery [3]. On the contrary, two reports 
suggested that perioperative FIO2 of 0.8 did not prevent PONV after general anesthesia for 
short ambulatory gynecologic laparoscopic procedures [4,5] (Table 1). A factorial trial of six 
interventions for the prevention of postoperative nausea and vomiting which included mixed 
general and gynecological surgery found no differences in the incidence of PONV in patients 
receiving FIO2 of 0.8 when compared with FIO2 of 0.3  but the effect of oxygen on early 
PONV was not analyzed [6]. Recent meta-analysis concluded that FIO2 of 0.8 compared with 
FIO2 of 0.3-0.4 did not reduce PONV after general anesthesia for abdominal and non-
abdominal surgery although the early vomiting was significantly reduced in abdominal 
surgery patients [7]. Nevertheless, studies with patients receiving FIO2 of 0.5 were excluded 
from the meta-analysis. FIO2 of 0.5 is more commonly used in anesthesia practice when 
higher FIO2 is desirable. One study found no effect of FIO2 of 0.5 on PONV in patients 
undergoing breast surgery but suggested beneficial effect on early postoperative vomiting [8]. 
Recent PONV consensus panel concluded that supplemental oxygen had no beneficial effects 
on PONV. However, this conclusion was based on FIO2 of 0.8 [9]. There is paucity of data on 
the influence of FIO2 of 0.5 on PONV and the effects of oxygen on early and late PONV.  
We therefore designed a prospective, randomized, controlled, double blind study to test the 
hypothesis that high intraoperative oxygen (FIO2 of 0.5 and FIO2 of 0.8) compared with 
 5 
routine FIO2 0.3 reduces the incidence of nausea and vomiting over the initial 24 
postoperative hours  in  women underwent elective gynecological laparoscopic surgery during 
general anesthesia. The potential for the dose/response effects in reducing the incidence of 
PONV with higher FIO2 was evaluated as well. 
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Methods 
 
          After the local ethics committee approval, written informed consent was obtained from 
120 adult patients classified as ASA (American Society of Anesthesiologists) physical status I 
and II, presenting for elective laparoscopic gynecological surgery at General Hospital Zadar, 
Croatia. The exclusion criteria were as follows: obesity (BMI >30 kg/m²), pulmonary 
diseases, pregnancy or breast feeding, known hypersensitivity to drugs used in the study 
protocol, use of antiemetics, psychotropic drugs, hormones and steroids within three days 
before surgery. Patients with comorbidities that may have an influence on PONV were also 
excluded, i.e. diseases which impaired gastric motility (diabetes mellitus, chronic 
cholecystitis, gastric and intestinal disease, neuromuscular disorders, neuropathies and liver 
dysfunction), vestibular disease, history of migraine headache, central nervous system injury, 
renal impairment, irregular menstrual cycles (duration of <21 or >35 days and/or variations 
between cycles >4 days), alcoholism and opioid addiction. After study enrollment, patients 
were excluded if they unexpectedly developed intraoperative drug allergy, severe 
intraoperative hypotension, perioperative hypoxia, excessive blood loss, difficult intubation, 
in open procedures or postoperative complications. 
All patients received 7.5 mg of midazolam PO 1 hour before the surgery with no prophylactic 
antiemetics. Standard monitoring was used including electrocardiography, noninvasive blood 
pressure, pulse oximetry and capnography. Anesthesia was induced with thiopental 5 mg/kg, 
fentanyl 1-2 µg/kg, and vecuronium 0.1 mg/kg IV. Patients' lungs were manually ventilated 
via face mask with oxygen FIO2=1.0 for 3 minutes before endotracheal intubation. Patients 
were randomized by computer-generated random numbers to receive a gas mixture consisting 
of 30% oxygen in air (FIO2=0.3, group G30), 50% oxygen in air (FIO2=0.5, group G50) or 
80% oxygen in air (FIO2=0.8, group G80). Anesthesia was maintained with sevoflurane (end 
tidal concentration ~1 minimum alveolar concentration [MAC], 1.5 - 2 vol% ) and 
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supplemental bolus doses of fentanyl IV (1 µg/kg) to keep heart rate and blood pressure 
within 20% of baseline values and additional vecuronium was administered to maintain one 
or two twitches on the train-of-four monitor. All patients received 10 ml/kg/h of crystalloids 
during surgery. Insertion of a nasogastric tube was not used. Patients' lungs were 
mechanically ventilated to keep normocapnia (end tidal CO2 32-38 mmHg). All laparoscopies 
were performed with CO2 insufflation and the patients were placed in a Trendelenburg 
position. Sevoflurane was discontinued at the start of skin closure. At the end of surgery 
neuromuscular blockade was antagonized with neostigmine 2.5 mg and atropine 1 mg IV. 
Postoperatively, patients received 5 ml/kg/h of crystalloids and were allowed to drink after the 
first 3 hours, if tolerated. After the surgery all patients breathed room air during the 24 hours 
follow-up period. The incidence of postoperative nausea (PON), vomiting (POV) and the use 
of rescue antiemetic were collected at 2 and 24 hours after surgery. Severity of postoperative 
nausea and pain were evaluated using a 100 mm visual analog scale (VAS) at the same time 
points (VAS 0 = no pain/nausea, 100 = maximal pain/nausea). A nausea VAS score was 
measured for each episode, but the highest score during the early (0-2h) and the late (2-24h) 
period was used for statistical analysis. 
Patients were considered to have had PONV if they experienced at least one episode of 
nausea, vomiting or retching or any combination of these during initial 24 postoperative 
hours. Postoperative vomiting was defined as at least one episode of vomiting or retching that 
occurred within 24 postoperative hours. PONV was defined as early (within first 2 hours in 
postoperative recovery area) or late (2-24 postoperative hours, on the ward). Three clinical 
nurses, specifically trained for the study, blinded to the randomization and the anesthesia 
technique used, collected the data. Metoclopramide 0.2 mg/kg IV was used as the rescue 
antiemetic and repeated if necessary. The administration of rescue antiemetic was based on 
the following criteria: patients who had two or more episodes of vomiting or retching within a 
period of 30 min, any nausea lasting more than 15 min or nausea VAS score 50 mm or 
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greater, or when a patient requested treatment. Pain VAS score and total amount of 
postoperative opioids were recorded at 2h and 24 hours after surgery. Diclofenac 75 mg IM 
was given immediately after surgery and if needed 12 hours later. For severe pain (VAS >40 
mm) meperidine 25 mg up to 100 mg IV was used. All patients stayed in the hospital for at 
least 24 hours. 
          Sample size calculations as well as power analysis were analyzed by nQuery Advisor 
7.0 (Statistical Solutions, Saugus, MA, USA). Sample size calculation was based on expected 
incidence of PONV 44% in group G30 and 50% reduction of PONV based on the data from a 
published study in gynecologic laparoscopic surgery [3]. Power analysis showed that 37 
patients per group would provide 80% power for detecting 50% reduction in the incidence of 
PONV with each treatment at a 2-sided α level of 0.05. Forty patients were randomized to 
each group to allow 5 to 10 % drop out rate. The data were analyzed using GraphPad Prism 5, 
v. 5.01 GraphPad Software Inc, San Diego, CA, USA. Quantitative values like demographic 
data, number of vomiting episodes per patient, VAS data and PONV risk scores were 
compared among three groups using ANOVA or Kruskal-Wallis test. Demographic 
categorical data, the incidence of nausea and vomiting as well as incidence of nausea and 
vomiting separately and metoclopramide administration were analyzed by Pearson Chi-
Square and Fisher's exact test where appropriate. Risk scores for PONV were calculated 
according to Apfel et al. [10]. Linear trend in reducing the incidence of POV with higher FIO2 
was tested by the Chi squared test for linear trend. Data were expressed as mean values (SD), 
median and range (minimal and maximal value) or number, percentage and 95% confidence 
interval (CI). P value of < 0.05 was considered statistically significant. 
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 Results 
 
          One hundred and eight of 120 patients, between 21 and 76 years old, completed the 
study (G30=36, G50=36, G80=36). A total of 12 patients were excluded from the analysis 
(Figure 1). Patients' demographic, intraoperative data and PONV risk scores were not 
different among the three groups (Table 2). The incidence of early vomiting was significantly 
decreased with increasing FIO2 (Table 3). FIO2 of 0.8 significantly decreased the incidence of 
early postoperative vomiting compared with FIO2 of 0.3, 3%, (1/36; 95% CI 0.07-14)  and 
22%, (8/36; 95% CI 10-39), respectively (P=0.028). There was no difference in early POV in 
G50, 11%, (4/36; 95% CI 3-26) vs. G30, 22%, (8/36; 95% CI 10-39) (P=0.343) nor G80, 3%, 
(1/36; 95% CI 0.07-14) vs. G50, 11%, (4/36; 95% CI 3-26) (P=0.357) (Table 3). The 
incidence of vomiting was reduced in groups with supplemental oxygen, G50 and G80, but 
there was no overall difference among the three groups at 24 hours (Table 3). Patients with 
higher oxygen inspiratory fraction had fewer number of vomiting episodes (Table 3). There 
was no difference in severe vomiting G30=5 patients (14%), G50=0 and G80=3(8%), 
P=0.077. The incidence of nausea was not significantly different among groups, neither for 
early nor late postoperative period. VAS scores for nausea were not significantly different 
among groups. There was no difference in the incidence of severe nausea G30=8 (22%), 
G50=5 (14%) and G80=6 (17%), P=0.639.   
Patients received same amount of the rescue antiemetic metoclopramide G30=8 patients 
(22%), G50=5 (14%) and G80=5 (14%), P=0.549. The VAS pain scores at 2h and 24 hours 
after surgery were similar among groups (Table 4). Amount of intraoperative opioids and 
postoperative pain medications were similar among the three groups (Table 4). There were no 
other adverse events reported. 
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Discussion 
 
          Our study suggests that higher intraoperative inspired oxygen fractions FIO2 0.8 and 
FIO2 0.5 in comparison with routine FIO2 0.3 have no effect on PONV in first 24 hours after 
gynecologic laparoscopic surgery. FIO2 of 0.8 as compared with FIO2 of 0.3 decreases the 
incidence of early postoperative vomiting, from 22% to 3 %. The number of vomiting 
episodes was also decreased. 
The influence of supplemental perioperative O2 in laparoscopic gynecological surgery was 
rarely investigated only in 2 published studies with opposite results [3,5]. Goll et al. [3] found 
that FIO2 of 0.8 when administered during gynecologic laparoscopic surgery halved the 
incidence of PONV for 24 postoperative hours from 44% to 22% compared with FIO2 of 0.3. 
On the contrary, Purhonen et al. [5] found that perioperative FIO2 of 0.8 did not reduce the 
incidence of PONV after ambulatory gynecological laparoscopy, which is in agreement with 
our findings. That study [5] did not find any difference in early vomiting although the number 
of patients who vomited in PACU was higher in FIO2 of 0.3 than in FIO2 of 0.8 group. The 
incidence of early vomiting in our study was significantly higher in patients with FIO2 of 0.3 
compared to Purhonen study, 22% vs. 8%, respectively.  
Purhonen’s group [8] investigated influence of FIO2 of 0.5 in breast surgery and did not find 
the difference in PONV compared with FIO2 of 0.3, 89% vs. 82%, at 24 hours, but the 
incidence of POV at 2 hours was significantly different, 0% vs. 12%, respectively. In the 
current study only FIO2 of 0.8 decreased the incidence of early POV compared with FIO2 of 
0.3 (Table 3). The incidence of early vomiting was decreased as FIO2 increased. Only one 
study attempted to correlate the influence of three different intraoperative FIO2 (0.3, 0.5 and 
0.8) on PONV after general anesthesia in breast surgery patients [11]. This study found no 
difference in the incidence of PONV 24 hours postoperatively, 35% vs. 45% vs. 30%, 
respectively [11]. However, the decreased incidence of early PONV (30% vs. 20% vs. 10%) 
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with increasing FIO2 (FIO2 0.3, FIO2 0.5 and FIO2 0.8, respectively) showed similar results. 
There appears to be a dose response relationship for early POV. This is suggested by 
statistically significant linear trend (P=0.01), as tested by the Chi squared test for linear trend, 
in reducing the incidence of POV with higher FIO2 (Table 3). A .larger prospective study 
would be needed to confirm this relationship. 
Recent meta-analysis [7] showed that FIO2 of 0.8 compared with FIO2 0.3-0.4 does not 
decrease incidence of PONV in abdominal and non-abdominal surgery at 24 hours. Early 
POV was not found to be decreased in non-abdominal surgery, but was decreased in 
abdominal surgery in the high FIO2 group. This suggests that the mechanism might be 
intestinal ischemia and release of short acting metabolites which triggers POV. Although 
serotonin was suggested as a trigger for POV after abdominal surgery, its role in POV was 
disputed, since serotonin plasma half life is only few minutes and peaks intraoperatively with 
no active metabolites postoperatively [7,12]. 
FIO2 of 0.5 was evaluated because it is commonly used in anesthesia practice when higher 
supplemental oxygen is desired. Use of FIO2 higher than 0.5 is not without risks [13-17]. 
There were no side effects related to high FIO2 administration. 
There are several limitations to this study. The results may not be generalized to other 
populations as the results were obtained for only one type of surgery and from a single 
hospital. The power analysis was calculated according to results of published data but the base 
incidence was less (44% vs. 36%, respectively) [3]. Therefore, the study may have not enough 
power to show statistical difference among all groups to avoid type I statistical error. 
Assuming the same trend in the incidence of early POV were to persist, a study with sample 
size of 175 patients in each group would have been necessary to produce a statistically 
significant difference among each of three groups with a power of 0.8 and α < 0.05. Expected 
intervention effect of 50% PONV reduction based on two previously published studies in 
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gynecological laparoscopy might to be too optimistic when compared with single antiemetic 
risk reduction by 26% in a factorial trial of six interventions for the prevention of PONV 
[3,5,6].   
In conclusion, higher intraoperative oxygenation did not reduce the PONV during first 24 
hours, however it decreased the incidence of early postoperative vomiting. Therefore, in 
patients undergoing surgical procedures associated with higher risk of PONV, such as 
laparoscopic gynecologic surgery, the use of high inspired oxygen concentrations has limited 
role in preventing the occurrence of this adverse event, and cannot be recommended as a part 
of routine anti-PONV strategy.  
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FIGURE 1 Flow diagram of patients’ distribution. 
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TABLE 1 Studies about the influence of high inspired oxygen fractions (FIO2) on the 
incidence of PONV cited. 
 
Reference 
[Number] 
Oxygen concentration 
(n) 
Type of 
anesthesia/ 
surgery 
Supplemental 
oxygen 
administration 
Outcomes Incidence of PONV 
significance 
Goll et al., 
2001. 
 [3] 
30% (80) vs. 80% (79) 
vs. 30% + ondansetron 
(81) 
general/ 
gynecologic  
laparoscopic 
surgery >1h           
intraoperative+ 
2h postop. 2L/minO2              
PON, POV,  PONV  
(0-6h, 6-24h, 0-24h)
 
 
PONV at 24 h (44% vs. 22% vs. 30%) 
Significant reduction with 80% O
 
McKeen et al.  
(abstract) 
2007. 
 [4] 
30% (145) vs. 80% 
(147) 
general/ 
ambulatory 
laparoscopic 
tubal ligation 
intraoperative   PON, POV, PONV 
(PACU stay, post-
discharge, 0-24h) 
PONV 24h (65.3% vs. 68.7%), P=0.62
Purhonen et al. 
2003. 
[5] 
30% (50) vs. 80% (49) general/ 
ambulatory  
gynecological  
laparoscopy    
intraoperative + 
1h postop.                             
PONV,PON, POV 
(PACU, step-down unit 
=Phase II,  
0-24h) 
PONV at 24h (62% vs.55%), P=0.486
Apfel et al. 
2004.  
[6]        
 
80% (280) vs. 30%  
(279) 
general/gynec
ologic + 
mixed surgery 
 
perioperative PONV (0-24h) PONV at 24h (31% vs. 24%
Orhan-Sungur 
et al. 2008.  
[7] 
meta-analysis 10 
studies  30%-40% 
(869) vs. 80% (860)  
general/gynec
ologic + 
mixed surgery 
intraoperative,  
perioperative                                         
 
PONV(0-6h, 6-24h,  
0-24h) 
PONV at 24h (33% vs. 30%
Significant reduction POV at 2h with 80% O
RR 0.42 [95%CI]= 0.22
 
Purhonen et al. 
2003.  
[8]                   
30% (49) vs. 50% (47)                              general/breast 
surgery       
intraop. + 2h postop.    PONV,PON, POV (0-2h, 
2-6h, 6-24h, 0-24h)                                                                                               
PONV at 24h (82% vs. 89%), P>0.05,
Significant reduction POV at 2h (12% vs. 0) with 50% 
O2, P<0.05  
 
Bhatnagar et 
al. 2005. 
[11] 
30% (20) vs. 50% (20) 
vs. 80% (20) 
general/ 
radical 
mastectomy 
intraop.+ postop.(if 
O2 saturation <95%)                      
PONV (0-2h, 2-6h, 6-24h, 
0-24h), PON (0-24h) 
 
PONV at 24h (35% vs. 45% vs. 30%), P=0.605,
PONV at 2h (30% vs. 20% vs. 10%), P=0.286
 
 
 
RR= Relative Risk, OR= Odds Ratio, CI=Confidence Interval, n=study subjects  
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TABLE 2 Patients’ demographics. 
 G30 (n=36) G50 (n=36)    G80  (n=36) 
Age (yr) 35.0 ± 9.9 37.2 ± 7.9 41.4 ± 15.1 
BMI (kg/m²) 22.5 ± 3.2 23.0 ± 3.6 22.8 ± 2.7 
ASA physical status (I/II) 29 / 7 29 / 7 23 / 13 
Smoking   n (%) 16 (44%) 18 (50%) 16 (44%) 
History of motion sickness 
and/or PONV    n (%) 
 
11 (31%) 
 
15 (42%) 
 
13 (36%) 
Duration of anesthesia (min) 74.2 ± 38.7 74.4 ± 34.5 60.5 ± 25.1 
Duration of surgery (min) 56.4 ± 36.5 57.0 ± 33.6 44.0 ± 23.4 
Type of surgery (n) 
    Ovarian cystectomy / 
    Tumor resection 
    Myomectomy 
    Laparoscopic assisted  
       vaginal hysterectomy 
    Laparoscopy for infertility 
 
 
22 
5 
 
3 
6 
 
 
19 
12 
 
0 
5 
 
 
22 
5 
 
0 
9 
Risk score for PONV* n (%) 
1 
2 
3 
4 
 
10 (28%) 
15 (42%) 
11 (31%) 
0 (0%) 
 
7 (19%) 
15 (42%) 
11 (31%) 
3 (8%) 
 
11 (31%) 
11 (31%) 
12 (33%) 
2 (6%) 
Average number of risk 
scores  
2.03 ± 0.77 2.14 ± 0.93 2.28 ± 0.88 
 
No statistical differences among groups (G30= FIO2 0.3, G50=FIO2 0.5, G80=FIO2 0.8).  
Data presented as mean ± SD or n (%).  
* Simplified risk score for PONV by Apfel et al.: female gender, history of motion sickness or 
PONV, non-smoking, the use of postoperative opioids. None, one, two, three or four risk 
factors indicate 10%, 21%, 39%, 61% or 79% incidence of PONV.  
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TABLE 3 Postoperative nausea and vomiting after laparoscopic gynecological surgery. 
 
        G30 
     FIO2 0.3 
(n=36) 
      G50 
FIO2 0.5 
(n=36) 
       G80 
FIO2 0.8 
(n=36) 
 
P 
PONV (24h)  (n, %) 13 (36%) 9 (25%) 12 (33%) 0.572 
PONV (0-2h)  (n, %) 10 (28%) 7 (19%) 6 (17%) 0.488 
PONV (2-24h) (n, %) 7 (19%) 3 ( 8%) 8 (22%) 0.247 
Nausea (24h) (n, %) 12 (33%) 9 (25%) 11 (31%) 0.733 
Nausea (0-2h) (n, %) 9 (25%) 7 (19%) 6 (17%) 0.671 
Nausea (2-24h) (n, %) 6 (17%) 3 ( 8%) 7 (19%) 0.385 
Nausea VAS scores 
(mm)ª 
42.5 (19.0-
80.0) 
30.0 (20.0-
80.0) 
50.0 (20.0-
60.0) 
0.590 
POV (24h) (n, %) 11 (31%) 7 (19%) 7 (19%) 0.435 
POV (0-2h) (n, %) 8 (22%) 4 (11%) 1 (3%)† 0.039* 
POV (2-24h) (n, %) 6 (17%) 3 ( 8%) 6 (17%) 0.498 
Vomiting episodes              
in patient who vomitedª 
2 (1-5) 1 (1-2)† 1 (1-3) 0.010* 
ª Data presented as median and range (minimal - maximal value). 
PONV - postoperative nausea and/or vomiting 
POV - postoperative vomiting  
* - statistically significant difference (P< 0.05) 
† - statistically significant vs. G30 group (P< 0.05) 
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TABLE 4 Pain visual analog scale (VAS) score and the amount of opioid use. 
 
 G30 (n=36) G50 (n=36) G80 (n=36) P 
Pain VAS scores (mm) 
Postop at   2 h 
                 24 h 
 
20.0 (0-58.0) 
20.0 (0-25.0) 
 
20.0 (10.0-50.0) 
10.0 (0-30.0) 
 
20.0 (10.0-50.0) 
10.0 (0-40.0) 
 
0.646 
0.151 
Intraoperative fentanyl 
(µg)                     
 
188 (75-450) 
 
200 (100-300) 
 
200 (100-300) 
 
0.06 
Postoperative 
meperidine (mg) 
 
0 (0-100)   
 
0 (0-50) 
 
0 (0-65) 
 
0.276 
 
All data are median and range (minimal – maximal value). 
 
 
